DSC Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-292,500
| Closed | -$2.98M | – | 32 |
|
2023
Q3 | $2.98M | Sell |
292,500
-17,500
| -6% | -$179K | 3.83% | 8 |
|
2023
Q2 | $2.33M | Buy |
310,000
+130,000
| +72% | +$979K | 3.5% | 8 |
|
2023
Q1 | $1.59M | Buy |
+180,000
| New | +$1.59M | 1.39% | 7 |
|
2022
Q4 | – | Sell |
-90,000
| Closed | -$726K | – | 81 |
|
2022
Q3 | $726K | Buy |
+90,000
| New | +$726K | 0.75% | 23 |
|